Tim Funnell
Director & Interim CEO at Ascend Gene & Cell Therapies · Investor at Monograph Capital
Investments
4
Lead Investments
2
Highlights
Focus Areas
Biotechnology
Health Care
Information Technology
Medical
Therapeutics
Firms Invested Under
Recent Investments
